Latest news
Denali Therapeutics Inc. (NASDAQ:DNLI) Given Average Rating of "Moderate Buy" by Analysts - MarketBeatMarketBeat · Sat, 08 Aug 2026 06:47:15 GMTDenali Therapeutics Q2 2026 Earnings Call Transcript - MarketBeatMarketBeat · Fri, 07 Aug 2026 05:57:51 GMTDenali Therapeutics Q2 Earnings Call Highlights - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 01:03:00 GMTGroupama Asset Managment Grows Stock Position in Denali Therapeutics Inc. $DNLI - MarketBeatMarketBeat · Sat, 01 Aug 2026 11:29:52 GMTDenali Therapeutics (DNLI) to Release Earnings on Thursday - MarketBeatMarketBeat · Thu, 30 Jul 2026 07:00:00 GMTDenali Therapeutics Inc. $DNLI is ADAR1 Capital Management LLC's 10th Largest Position - MarketBeatMarketBeat · Wed, 29 Jul 2026 07:00:00 GMT